CAMP4 Therapeutics Corporation
CAMP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$15,099 | -$12,587 | -$12,433 | -$13,279 |
| Dep. & Amort. | $416 | $430 | $421 | $418 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $984 | $1,002 | $861 | $797 |
| Change in WC | -$369 | $618 | -$3,511 | $768 |
| Other Non-Cash | $2,851 | $194 | $376 | $8 |
| Operating Cash Flow | -$11,217 | -$10,343 | -$14,286 | -$11,288 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $36 | -$279 | -$279 | -$263 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $36 | -$279 | -$279 | -$263 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$14 | $72 | -$151 | -$211 |
| Stock Issued | $32,562 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $14,836 | $0 | $0 | $73,273 |
| Financing Cash Flow | $47,384 | $72 | -$151 | $73,062 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $36,203 | -$10,550 | -$14,716 | $61,511 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $40,676 | $50,947 | $65,663 | $4,152 |
| End Cash | $76,879 | $40,397 | $50,947 | $65,663 |
| Free Cash Flow | -$11,217 | -$10,343 | -$14,565 | -$11,551 |